Drug firm Sanofi India reported a 57.98 percent decline in net profit at Rs 50.5 crore for the fourth quarter ended December 2016 on account of higher expenses.
The company had reported a net profit of Rs 120.2 crore in the same period a year ago, Sanofi India said in a BSE filing.
The company follows the January-December financial year.
Net sales increased to Rs 592 crore during the quarter under review as compared to Rs 568.7 crore in the same period last fiscal.
Total expenses stood at Rs 525.9 crore during the October-December quarter of 2016, up 8.34 percent from Rs 485.4 crore in the year-ago period.
In a separate filing, Sanofi India said its board has recommended a final dividend of Rs 50 per equity share of Rs 10 for the year ended December 2016.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
